search
antibiotics
Trends
- 1New Blood Test Distinguishes Bacterial and Viral Infections in Newborns▼Blood Test Differentiates Bacterial and Viral Infections in Newborns
A new blood test can differentiate between bacterial and viral infections in newborns, according to a report by Inside Precision Medicine. The development could help doctors decide when antibiotics are truly needed in infants, where diagnosing infection has long been difficult and often leads to precautionary antibiotic use. The finding is drawing attention in medical and precision diagnostics circles.
- 2University of Kansas wins $5.8 million NIH grant against antibiotic resistance▼University of Kansas Lands $5.8 Million NIH Grant to Fight Antibiotic Resistance
The University of Kansas has been awarded a $5.8 million grant from the National Institutes of Health to support research into combating antibiotic resistance. The funding will back efforts to develop new approaches as drug-resistant bacteria remain a growing global health threat, with the university positioned among institutions receiving major federal support for this work.
- 3Colombian Mosquitoes and Sand Flies Carry Hidden Viruses and Resistance Genes▼Hidden Viral Worlds and Antibiotic Resistance Genes Found in Colombian Mosquitoes and Sand Flies
Researchers in Colombia have identified previously unknown viruses and antibiotic resistance genes in mosquitoes and sand flies, revealing that these disease-carrying insects host far more microbial life than expected. The findings suggest the insects could play a role in spreading antimicrobial resistance, adding a new dimension to concerns about mosquito-borne disease in the region.
- 4New PCR Test Detects Macrolide-Resistant Mycoplasma pneumoniae in Hours●Fluorescence PCR Test Spots Macrolide-Resistant Mycoplasma pneumoniae in Hours
A fluorescence-based PCR test has been developed that can identify macrolide-resistant Mycoplasma pneumoniae, the bacterium behind common respiratory infections, within hours rather than days. Rapid detection of resistance matters because macrolides are a first-line treatment, and resistant strains force clinicians to switch therapies. The test could help doctors choose effective antibiotics sooner and support surveillance of resistant mycoplasma strains.